Jonathan Rose, Author at MarketWise

Tesla Optimus, Grok, and TSLA Stock: What’s Real. What’s Hype. What the Filings Actually Show.

While Tesla Optimus, Grok and the Cybercab grab headlines, here’s what the filings actually show – and what it means for TSLA stock.

By Jonathan Rose | September 4, 2026

Read this issue

August Jobs Report Preview: Forget the VIX — Watch the Bond Market Going Into Friday

While the VIX stays calm, our August jobs report preview shows the bond market flashing a warning into Friday's release.

By Jonathan Rose | September 2, 2026

Read this issue

CoreWeave Stock: The $2.6 Billion Debt Signal the AI Bubble Is Ignoring

CoreWeave's $2.6 billion loan reveals hidden risks facing AI infrastructure stocks. Learn what the credit market is signaling about the AI buildout.

By Jonathan Rose | August 27, 2026

Read this issue

Moderna Breakthrough Sends MRNA Soaring: 4 mRNA Cancer Vaccine Stocks to Buy Instead

mRNA cancer vaccine stocks are booming. Don't chase the 177% Moderna spike—buy these 4 sector winners instead.

By Jonathan Rose | August 20, 2026

Read this issue

Boeing-Archer Deal: Why Give Away a $200 Million Business — on Purpose?

The Boeing-Archer deal gave away a $200M drone business for zero cash. Why Boeing made the trade — and which physical AI stocks rallied sharply on the news.

By Jonathan Rose | August 10, 2026

Read this issue

The Yield Curve Just Steepened Hard — Here’s What It Means for Stocks, Banks, and Your Bonds

Yield curve steepening just hit hard as Treasury yields diverged sharply. A 28-year floor trader explains what it all means, and who wins from here.

By Jonathan Rose | August 5, 2026

Read this issue